Home » Topics » BioWorld Science

BioWorld Science
RSS

Medshine Discovery patents MAPK 14 inhibitors

April 20, 2018

Vertex Pharmaceuticals identifies new PAR-2 antagonists

April 20, 2018

Plexxikon divulges novel IDO1 and/or TDO inhibitors

April 20, 2018

Relay Therapeutics and collaborator patent PTP-2C inhibitors

April 20, 2018

EMA committee hands down negative opinion for masitinib in ALS

April 20, 2018

Novel genetically altered broadly neutralizing antibodies protect monkeys from SHIV

April 20, 2018

FDA advisory committee recommends approval of Epidiolex for LGS and Dravet syndrome

April 20, 2018

Johnson & Johnson reviews progress of first quarter 2018

April 20, 2018

ADC Therapeutics presents potent antitumoral compounds in xenograft models

April 20, 2018

FDA accepts Veloxis' sNDA for Envarsus XR

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...